GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 6:41 PM ET

    Baxter International Inc. rose$. 41 or. 6 percent, to $74.48. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $61.30. Hospira rose$. 22 or. 4 percent, to $62.66.

  • Midday Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $74.29. Bristol-Myers Squibb Co. rose$. 15 or. 2 percent, to $60.94. Hospira rose$. 18 or. 3 percent, to $62.62.

  • Early Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 10:20 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $73.57. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.06. Hospira fell$. 02 or percent, to $62.42.

  • INDIANAPOLIS— Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing. Lilly said Friday that it will pay $50 million upfront and an additional $280 million and $240 million if the insulin reaches some development and sales...

  • Final Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 8:09 PM ET

    Baxter International Inc. rose $1.80 or 2.5 percent, to $74.07. Bristol-Myers Squibb Co. rose $1.60 or 2.7 percent, to $60.79. Hospira rose $2.19 or 3.6 percent, to $62.44.

  • Midday Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 1:48 PM ET

    Baxter International Inc. rose $1.12 or 1.5 percent, to $73.39. Bristol-Myers Squibb Co. rose $1.16 or 2.0 percent, to $60.35. Hospira rose $1.44 or 2.4 percent, to $61.69.

  • Early Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 11:11 AM ET

    Baxter International Inc. rose$. 94 or 1.3 percent, to $73.21. Bristol-Myers Squibb Co. rose$. 69 or 1.2 percent, to $59.88. Hospira rose$. 68 or 1.1 percent, to $60.93.

  • Final Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Baxter International Inc. rose $1.54 or 2.2 percent, to $72.27. Bristol-Myers Squibb Co. rose $1.50 or 2.6 percent, to $59.19. Hospira rose $1.43 or 2.4 percent, to $60.25.

  • Midday Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 93 or 1.3 percent, to $71.66. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $58.34. Hospira rose $1.11 or 1.9 percent, to $59.93.

  • Early Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 10:16 AM ET

    Baxter International Inc. rose$. 83 or 1.2 percent, to $71.56. Bristol-Myers Squibb Co. rose$. 24 or. 4 percent, to $57.93. Eli Lilly& Co. rose$. 24 or. 3 percent, to $69.50.

  • Final Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 6:41 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 86 or 1.5 percent, to $57.69. Hospira fell $1.52 or 2.5 percent, to $58.82.

  • Midday Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 1:20 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $71.46. Bristol-Myers Squibb Co. fell$. 28 or. 5 percent, to $58.27. Hospira fell$. 57 or. 9 percent, to $59.77.

  • Eli Lilly bumps up dividend for first time since 2009 Tuesday, 16 Dec 2014 | 10:44 AM ET

    INDIANAPOLIS— Shares of Eli Lilly outpaced broader trading indexes Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years. That will raise the quarterly payout to 50 cents per share, or $2 annually. Eli Lilly and Co. shares climbed about 1 percent, or 71 cents, to $70.38 Tuesday, while the Standard& Poor's 500 index...

  • Early Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 10:20 AM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $71.06. Bristol-Myers Squibb Co. fell$. 63 or 1.1 percent, to $57.92. Hospira fell$. 37 or. 6 percent, to $59.97.

  • Final Glance: Pharmaceuticals companies Monday, 15 Dec 2014 | 6:08 PM ET

    Baxter International Inc. fell$. 67 or. 9 percent, to $71.10. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $58.55. Hospira rose$. 01 or percent, to $60.34.

  • Early Glance: Pharmaceuticals companies Monday, 15 Dec 2014 | 12:00 PM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $71.92. Bristol-Myers Squibb Co. fell$. 15 or. 3 percent, to $58.60. Hospira rose $1.01 or 1.7 percent, to $61.34.

  • Final Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 6:03 PM ET

    Baxter International Inc. fell $1.34 or 1.8 percent, to $71.77. Bristol-Myers Squibb Co. fell$. 93 or 1.6 percent, to $58.75. Hospira fell $1.75 or 2.8 percent, to $60.33.

  • Midday Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 96 or 1.3 percent, to $72.15. Bristol-Myers Squibb Co. fell$. 44 or. 7 percent, to $59.24. Hospira fell$. 67 or 1.1 percent, to $61.41.

  • Early Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 10:31 AM ET

    Baxter International Inc. fell$. 57 or. 8 percent, to $72.54. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $59.85. Hospira fell$. 11 or. 2 percent, to $61.97.

  • ZURICH, Dec 12- Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson& Johnson's Stelara. The data follows results last year showing Cosentyx, also known as secukinumab, was superior to Amgen's Embrel in a head-to-head study. Other drugmakers working on new...